Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

ORNIDYL

EFLORNITHINE HYDROCHLORIDE

Standard Dose
200MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview ORNIDYL is listed in Drugs@FDA under application 019879 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient EFLORNITHINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 200MG/ML Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 2002-01-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview ORNIDYL is listed in Drugs@FDA under application 019879 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient EFLORNITHINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 200MG/ML Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 2002-01-03 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.